- Home
- FIVN vs IRON Comparison
FIVN vs IRON Comparison
Compare FIVN & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIVN
- IRON
- Stock Information
- Founded
- FIVN 2001
- IRON 2017
- Country
- FIVN United States
- IRON United States
- Employees
- FIVN N/A
- IRON 84
- Industry
- FIVN EDP Services
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- FIVN Technology
- IRON Health Care
- Exchange
- FIVN Nasdaq
- IRON Nasdaq
- Market Cap
- FIVN 2.1B
- IRON 2.1B
- IPO Year
- FIVN 2014
- IRON N/A
- Fundamental
- Price
- FIVN $25.84
- IRON $59.82
- Analyst Decision
- FIVN Buy
- IRON Strong Buy
- Analyst Count
- FIVN 19
- IRON 10
- Target Price
- FIVN $39.16
- IRON $97.80
- AVG Volume (30 Days)
- FIVN 1.8M
- IRON 301.7K
- Earning Date
- FIVN 11-06-2025
- IRON 11-11-2025
- Dividend Yield
- FIVN N/A
- IRON N/A
- EPS Growth
- FIVN N/A
- IRON N/A
- EPS
- FIVN 0.11
- IRON N/A
- Revenue
- FIVN $1,105,816,000.00
- IRON N/A
- Revenue This Year
- FIVN $12.39
- IRON N/A
- Revenue Next Year
- FIVN $9.39
- IRON N/A
- P/E Ratio
- FIVN $238.40
- IRON N/A
- Revenue Growth
- FIVN 14.21
- IRON N/A
- 52 Week Low
- FIVN $21.04
- IRON $30.82
- 52 Week High
- FIVN $49.90
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- FIVN 47.04
- IRON 50.30
- Support Level
- FIVN $25.16
- IRON $58.59
- Resistance Level
- FIVN $27.42
- IRON $61.27
- Average True Range (ATR)
- FIVN 0.93
- IRON 2.13
- MACD
- FIVN -0.05
- IRON -0.15
- Stochastic Oscillator
- FIVN 30.92
- IRON 18.47
About FIVN Five9 Inc.
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement, and various modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, as well as workforce optimization solutions that optimize call center efficiency, and manage interaction quality and agent performance.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.